MCC-257

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MCC-257, covering 2007-12-28 to 2007-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy [Phase 2]